1. Home
  2. TOVX vs MODD Comparison

TOVX vs MODD Comparison

Compare TOVX & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

N/A

Current Price

$0.16

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Logo Modular Medical Inc.

MODD

Modular Medical Inc.

N/A

Current Price

$1.33

Market Cap

11.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TOVX
MODD
Founded
2001
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
11.2M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
TOVX
MODD
Price
$0.16
$1.33
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $2.50
N/A
AVG Volume (30 Days)
★ 1.0M
117.8K
Earning Date
08-11-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 89.07
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.12
52 Week High
$0.49
$6.16

Technical Indicators

Market Signals
Indicator
TOVX
MODD
Relative Strength Index (RSI) 30.94 34.97
Support Level N/A $0.13
Resistance Level $0.25 $2.49
Average True Range (ATR) 0.02 0.23
MACD -0.00 -0.03
Stochastic Oscillator 35.19 21.84

Price Performance

Historical Comparison
TOVX
MODD

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: